Media ReleasesSienna Cancer Diagnostics

View All Sienna Cancer Diagnostics News

Sienna signs lease for new premises to facilitate the execution of its strategic goal to become an IVD Hub

  • Sienna advances its plans to become a hub for IVD test development and commercialisation
  • New premises are located near CSIRO and the Monash Technology Precinct
  • New manufacturing facilities for SIEN-NETTM product line to be built
Melbourne, Australia, 8 October 2019: Sienna Cancer Diagnostics Ltd (ASX: SDX) (“Sienna” or “the Company”), a medical technology company developing and commercialising innovative IVD tests, is expanding its operations and moving to a new location adjacent to CSIRO and the Monash Technology Precinct.

For further information please download the attached PDF: Download this document